Imunon, Inc. Reports Q2 Results for Quarter Ended June 30, 2026

What Happened

• Imunon, Inc. announced and furnished a press release on August 11, 2026 reporting its financial results for the quarter ended June 30, 2026 (reported under Item 2.02 of Form 8-K). The press release is included as Exhibit 99.1 to the filing.
• The company had previously announced on August 4, 2026 that it would hold a conference call and live webcast on August 11, 2026 to discuss the quarterly results and provide a business update.

Key Details

• Filing date: August 11, 2026; quarter covered: ended June 30, 2026.
• Exhibit listed: 99.1 — Press Release dated August 11, 2026 (also noted Inline XBRL cover page Exhibit 104).
• Company announced an earnings call and live webcast to review the results and business update (call/webcast held August 11, 2026).
• The information in the 8-K is furnished, not “filed,” and the press release includes forward‑looking statements with a cautionary note about risks and uncertainties.

Why It Matters

• This filing notifies investors that Imunon has released its quarterly financial results and held an investor call/webcast to discuss performance and business developments — key sources for assessing revenue, earnings, cash flow, and near‑term outlook.
• Because the 8-K furnishes (but does not “file”) the press release, the material is provided promptly to the market but is subject to the limited liability treatment noted in the filing; investors should read the press release and listen to the webcast for the specific financial figures and management commentary, and review the forward‑looking statement caution.